IFNG and hepatocellular carcinoma: In another study, Chang et al. (2010) demonstrated that the oral administration of FIP-fve reduced the tumor size of BNL hepatoma-bearing mice and suggested that the antitumor effect was mediated by IFN-γ-induced tumor growth inhibition effect involving both innate and specific immunity and ERK/MAPK signaling pathway.